Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, placebo-controlled trial of fampridine for cognitive function in multiple sclerosis
2013-002558-64Phase 4Completed
- Sponsor
- Dipartimento di Neurologia e Psichiatria
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in multiple sclerosis (MS) comparing Fampridine with Placebo (2 arms). Primary endpoint: Speed of information processing (SDMT). Started Oct 2013; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2013-002558-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002558-64.